ESC Guidelines: Controlling Diabetes (Arabic Version)

Torn again between the 2019 ESC Guidelines of Diabetes & the 2021 ESC Guidelines of CVD Prevention.
Let's have a resumé on the diagnosis & treatment of diabetes in cardiovascular patients.

2021 ESC Guidelines of CVD Prevention
https://www.escardio.org/Guidelines/C...


2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD
https://www.escardio.org/Guidelines/C...


https://www.thelancet.com/journals/la...
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)


https://www.nejm.org/doi/full/10.1056...
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus


https://www.ncbi.nlm.nih.gov/pmc/arti...
Association between seven years of intensive treatment of type 1 diabetes and long term mortality


https://www.ncbi.nlm.nih.gov/pmc/arti...
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview


https://diabetesjournals.org/care/a
Professional Practice Committee: Standards of Medical Care in Diabetes—2021

https://www.nejm.org/doi/full/10.1056...
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes


https://www.nejm.org/doi/full/10.1056....
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes


https://www.acc.org/latest-in-cardiol...
Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction - DAPA-HF